Edmond de Rothschild (Europe)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$890K Buy
11,252
+459
+4% +$37.3K 0.36% 43
2016
Q2
$900K Sell
10,793
-5,207
-33% -$462K 0.45% 33
2016
Q1
$1.47M Sell
16,000
-4,208
-21% -$379K 0.77% 29
2015
Q4
$2.04M Sell
20,208
-1,874
-8% -$195K 0.88% 27
2015
Q3
$2.17M Buy
22,082
+1,350
+7% +$150K 1.01% 22
2015
Q2
$2.43M Buy
+20,732
New +$2.27M 0.78% 35

Other funds holding GILD

Edmond de Rothschild (Europe)'s GILD Position: Q3 2016 in Review

Edmond de Rothschild (Europe) increased its Gilead Sciences (GILD) stake by 4.3% in Q3 2016, buying an estimated $37.3K and bringing the position to 11,252 shares worth $890K. The position accounts for 0.36% of the portfolio, ranked #43.

Edmond de Rothschild (Europe) first reported a position in GILD in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.43M in Q2 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Edmond de Rothschild (Europe) held 11,252 shares of Gilead Sciences worth $890K as of Q3 2016.
  • Edmond de Rothschild (Europe) bought 459 Gilead Sciences shares in Q3 2016, an estimated $37.3K.
  • Gilead Sciences made up 0.36% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #43 holding.
  • Edmond de Rothschild (Europe) first reported a position in Gilead Sciences in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Europe)'s Gilead Sciences position peaked at $2.43M in Q2 2015.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.